A confirmation study of anti-obesity effect by test food intake.
- Conditions
- Adults in good health
- Registration Number
- JPRN-UMIN000024947
- Lead Sponsor
- CPCC Company Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 24
Not provided
1) Subjects who are given continuous treatment by taking medicines. 2) Subjects who constantly use oral medicines, functional foods and/or supplements having a possibility of affecting test results. 3) Subjects who have previous and/or current medical history of serious disease in heart, liver, kidney and/or digestive trucks. 4) Pregnant or possibly pregnant females, or lactating females. 5) Subjects who excessive alcohol intake. 6) Subjects who have extremely irregular life rhythms, and subjects who have midnight work or irregular shift work. 7) Subjects who have previous medical history of drug and/or food allergy. 8) Subjects who are participating the other clinical tests of medicines or foods. Subjects who participated other clinical tests of medicines or foods within 4-weeks prior to the current study. 9) Subjects who donated over 200mL blood and/or blood components within a month to the current study. 10) Males who donated over 400mL blood within the last three months to the current study. 11) Females who donated over 400mL blood within the last four months to the current study. 12) Males who will be collected over 1200mL blood and/or blood components, when the sampling amounts within the last twelve months are adding to the planned sampling amounts of this study. 13) Females who will be collected over 800mL blood and/or blood components when, the sampling amounts within the last twelve months are adding to the planned sampling amounts of this study. 14) Others who have been determined ineligible by principal investigator or sub-investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Body weight, body mass index and body fat percentage.
- Secondary Outcome Measures
Name Time Method Intestinal microflora and blood lipid level.